Literature DB >> 16446133

The ups and downs of BDNF in Rett syndrome.

Yi E Sun1, Hao Wu.   

Abstract

Rett syndrome (RTT) is an X-linked postnatal neurodevelopmental disorder, which is primarily caused by mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2). A number of MeCP2 target genes have been identified, including the neurotrophic factor BDNF; however, the functional relevance of these targets has not been established. In this issue of Neuron, Chang et al. provide the first in vivo evidence for a functional interaction between BDNF and MeCP2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446133     DOI: 10.1016/j.neuron.2006.01.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  16 in total

Review 1.  Secreted factors as synaptic organizers.

Authors:  Erin M Johnson-Venkatesh; Hisashi Umemori
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

2.  Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders.

Authors:  Kirstie H Stansfield; J Richard Pilsner; Quan Lu; Robert O Wright; Tomás R Guilarte
Journal:  Toxicol Sci       Date:  2012-02-17       Impact factor: 4.849

3.  Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

Authors:  Emanuela Giacometti; Sandra Luikenhuis; Caroline Beard; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

5.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

6.  Synaptic maturation at cortical projections to the lateral amygdala in a mouse model of Rett syndrome.

Authors:  Frédéric Gambino; Malik Khelfaoui; Bernard Poulain; Thierry Bienvenu; Jamel Chelly; Yann Humeau
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

7.  MeCP2 repression of G9a in regulation of pain and morphine reward.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Paul J Kenny; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

8.  Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain-derived neurotrophic factor regulated slow calcium buffering.

Authors:  S L Mironov; E Skorova; N Hartelt; L A Mironova; M T Hasan; S Kügler
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

9.  Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.

Authors:  Cristina Borralleras; Ignasi Sahun; Luis A Pérez-Jurado; Victoria Campuzano
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

10.  MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy.

Authors:  Mojgan Rastegar; Akitsu Hotta; Peter Pasceri; Maisam Makarem; Aaron Y L Cheung; Shauna Elliott; Katya J Park; Megumi Adachi; Frederick S Jones; Ian D Clarke; Peter Dirks; James Ellis
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.